Alto Neuroscience Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alto Neuroscience Inc.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Alto Neuroscience Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alto Neuroscience Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alto Neuroscience Inc. is ANRO:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alto Neuroscience Inc. has its primary listing on New York Stock Exchange. You can trade Alto Neuroscience Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alto Neuroscience Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Alto Neuroscience Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Alto Neuroscience Inc..